BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24935062)

  • 1. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
    Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
    Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.
    Li Y; Zhang X; Chen D; Ma C
    Tumour Biol; 2016 Jun; 37(6):8107-19. PubMed ID: 26715270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratifin expression is a novel prognostic factor in human gliomas.
    Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
    Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of folate receptor -α protein expression in human gliomas and its clinical relevance].
    Wu H; Zhan Y; Qu Y; Qi X; Li J; Yu C
    Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):202-7. PubMed ID: 24785460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
    Lee CT; Wu TT; Lohse CM; Zhang L
    Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype.
    Wang H; Wang Y; Jiang C
    Int J Oncol; 2013 May; 42(5):1716-24. PubMed ID: 23467707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
    Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
    Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
    Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
    J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group I-C protein in astrocytoma and glioblastoma.
    Akai T; Ueda Y; Sasagawa Y; Hamada T; Date T; Katsuda S; Iizuka H; Okada Y; Chada K
    Pathol Res Pract; 2004; 200(9):619-24. PubMed ID: 15497774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.
    Lei X; Chang L; Ye W; Jiang C; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
    Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gab2 expression in glioma and its implications for tumor invasion.
    Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
    Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy.
    Thal D; Xavier CP; Rosentreter A; Linder S; Friedrichs B; Waha A; Pietsch T; Stumpf M; Noegel A; Clemen C
    J Pathol; 2008 Mar; 214(4):415-24. PubMed ID: 18189330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.
    Pang B; Fan H; Zhang IY; Liu B; Feng B; Meng L; Zhang R; Sadeghi S; Guo H; Pang Q
    J Neurooncol; 2012 Feb; 106(3):543-9. PubMed ID: 21984063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.